You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 10, 2024

CLINICAL TRIALS PROFILE FOR SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for salmonella typhi ty2 vi polysaccharide antigen

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00326443 ↗ CVD 909 Vi Prime Boost Study Completed National Institute of Allergy and Infectious Diseases (NIAID) Phase 1 2006-02-01 The purpose of this research study is to see if giving a typhoid vaccine by mouth (an experimental vaccine, CVD 909) before giving a vaccine shot (Typhim Vi) will result in a better immune response than giving Typhim Vi vaccine by itself. Another purpose is to see whether CVD 909 is safe. Typhim Vi has been shown to be safe and effective in preventing typhoid fever in older children and adults, but it does not work in children under age 2. Scientists at the University of Maryland think that young children could respond to Typhim Vi if they were given a dose of the other typhoid vaccine by mouth before they are given the Typhim Vi shot. Twenty-eight healthy adult volunteers, ages 18-40 years, will take part in this study. Study participation will last for up to 63 weeks, but most of the study visits will be in the first 6 weeks. Blood samples will be collected approximately 13 times. Four stool samples will be collected. Some volunteers may be followed for an additional 4 years.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for salmonella typhi ty2 vi polysaccharide antigen

Condition Name

Condition Name for salmonella typhi ty2 vi polysaccharide antigen
Intervention Trials
Typhoid Fever 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for salmonella typhi ty2 vi polysaccharide antigen
Intervention Trials
Typhoid Fever 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for salmonella typhi ty2 vi polysaccharide antigen

Trials by Country

Trials by Country for salmonella typhi ty2 vi polysaccharide antigen
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for salmonella typhi ty2 vi polysaccharide antigen
Location Trials
Maryland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for salmonella typhi ty2 vi polysaccharide antigen

Clinical Trial Phase

Clinical Trial Phase for salmonella typhi ty2 vi polysaccharide antigen
Clinical Trial Phase Trials
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for salmonella typhi ty2 vi polysaccharide antigen
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for salmonella typhi ty2 vi polysaccharide antigen

Sponsor Name

Sponsor Name for salmonella typhi ty2 vi polysaccharide antigen
Sponsor Trials
National Institute of Allergy and Infectious Diseases (NIAID) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for salmonella typhi ty2 vi polysaccharide antigen
Sponsor Trials
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.